Bio Medica Laboratories SME IPO Details
Bio Medica Laboratories is a pharmaceutical company established in 2015 and based in Indore, Madhya Pradesh. The company is engaged in manufacturing parenteral formulations such as liquid injectables and dry powder injections for both human and veterinary healthcare segments. It operates mainly on a B2B contract manufacturing model, supplying ethical drugs, generic medicines and OTC products to pharmaceutical companies across multiple Indian states. The company also has GMP and GLP certified manufacturing facilities with a growing presence in domestic and export markets.
IPO Review
IPO GMP
IPO Subscription Subscription
Stock Price
As the IPO is listed, here is the Live Share Price for Bio Medica Laboratories
IPO Summary
What is the Bio Medica Laboratories IPO Timetable?
Track the IPO schedule and key events.
| Event | Date | Day |
|---|---|---|
| IPO Open Date | 21 May, 2026 Thu | Thursday |
| IPO Close Date | 25 May, 2026 Mon | Monday |
| Basis of Allotment | 26 May, 2026 Tue | Tuesday |
| Refunds Initiated | 27 May, 2026 Wed | Wednesday |
| Credit to Demat | 27 May, 2026 Wed | Wednesday |
| Listing Date | 29 May, 2026 Fri | Friday |
What is the Bio Medica Laboratories IPO Lot Size?
Bidding in multiples of 1000 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2000 | ₹2,78,000 |
| Retail (Max) | 2 | 2000 | ₹2,78,000 |
| HNI (Min) | 3 | 3000 | ₹4,17,000 |
About Bio Medica Laboratories
The company operates on a business model centred around the development, production, and distribution of pharmaceutical formulations and healthcare solutions across multiple therapeutic segments. Its product offerings include tablets, capsules, syrups, injections, and other medical formulations supplied through distributors and healthcare networks. The business is promoted by experienced industry professionals who focus on expanding market reach, improving manufacturing capabilities, and strengthening the company’s position in the domestic pharmaceutical industry.
Objects of the Issue
| Issue Object | Estimate Amount |
|---|---|
Strengths & Risks
Strengths
- ✓ Experienced promoters and management team with pharma industry knowledge.
- ✓ Diversified portfolio of injectable pharmaceutical products for human and veterinary use.
- ✓ Strong quality assurance systems supported by GMP-certified manufacturing facilities.
- ✓ Established relationships with clients across multiple Indian states and healthcare markets.
- ✓ Significant improvement in revenue, EBITDA margins, and profitability during recent financial years.
Risks
- ⚠ High dependence on key customers may impact revenue if orders decline.
- ⚠ Any quality control failure could damage reputation and invite legal liabilities.
- ⚠ Failure to adopt new pharmaceutical technologies may affect future competitiveness.
- ⚠ Negative cash flow risks may create pressure on expansion and working capital needs.
- ⚠ The company operates from premises that are not fully owned, creating operational dependency risks.
Company Financials
Summary of financial performance including revenue, profit, and debt levels will be populated here.
Promoters and Shareholding Details
| Particular | % Share |
|---|---|
| Promoter Holding Pre Issue | 99.99 |
| Promoter Holding Post Issue | -- |
Frequently Asked Questions
What is the GMP of Bio Medica Laboratories?
The current Grey Market Premium (GMP) of Bio Medica Laboratories is ₹ 2.
What is the Bio Medica Laboratories IPO Price Band?
The price band for Bio Medica Laboratories IPO is 139.
When is the Bio Medica Laboratories IPO Allotment?
The allotment date for Bio Medica Laboratories IPO is May 26, 2026.
How to check Bio Medica Laboratories IPO Allotment Status?
You can check the allotment status on the IPO Allotment Status page or on the registrar's website (Skyline Financial Services Pvt.Ltd.).
Registrar
Skyline Financial Services Pvt.Ltd.
Discussion 0
No comments yet
Be the first to share your thoughts!